Global Perspectives on Precision Medicine
Contributors: Vasco Pontinha, Virginia Commonwealth University, Richmond, VA, USA; Ana Gonçalves, Charité – Universitätsmedizin, Berlin, Germany; Jacinda Tran, University of Washington, Seattle, WA, USA; Shrey Gohil, University of Houston, Houston, TX, USA.
Acknowledgement: We would like to thank Zeba Khan, RPh, PhD for her review and helpful comments.
References
1. Global Market Insights, Ugalmugle S., Swain R. Precision Medicine Market Size By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics), By Application (Oncology, Immunology, CNS, Respiratory), By End-use (Pharmaceutical Companies, Diagnostic Companies, Healthcare IT companies), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026. https://www.gminsights.com/industry-analysis/precision-medicine-market. Accessed November 2, 2020.
2. Personalized Medicine Coalition. Personalized Medicine At FDA: The Scope & Significance of Progress in 2019. http://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/PM_at_FDA_The_Scope_and_Significance_of_Progress_in_2019.pdf. Accessed November 2, 2020.
3. Spear BB, Heath-Chiozzi M, Huff J. Clinical application of pharmacogenetics. Trends Mol Med. 2001;7(5):201-204.
4. Tufts Center for the Study of Drug Development. Personalized medicine gains traction but still faces multiple challenges. Impact Report. 2015(17).
